Company Description : A development-stage pharmaceutical company, is engaged in the discovery, development and commercialization of products for the treatment of diseases and disorders in which the body is unable to mount an appropriate immune or metabolic response. url: www.holliseden.com
Hollis-Eden reports additional positive data from Triolex Phase I/II trial : BOSTON (Thomson Financial) - Hollis-Eden Pharmaceuticals Inc. Monday reported additional positive data from its on-going Phase I/II clinical trial with Triolex supporting an anti-inflammatory approach to treating type 2 diabetes...
Register for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.
Free Annual Report - Click Here!
Get the Latest Hollis-Eden Pharmaceuticals stock Price, quotes, trades and FREE Hollis-Eden Pharmaceuticals stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Hollis-Eden Pharmaceuticals (HEPH) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.